Nocivelli ABP, strong growth in H1 25-26. Top Line and Margins up, EBITDA at Euro 10.8 million (+10.1%). Backlog at 1.9 billion

PRESS RELEASE

• Value of Production: Euro 45.6 million, +8.2% (Euro 42.1 million in H1 24-25);
• Like-for-like Value of Production up 12.6%;
• Revenues from sales: Euro 42.8 million, +3.7% (Euro 41.3 million in H1 24-25);
• EBITDA: Euro 10.8 million, +10.1% (Euro 9.8 million in H1 24-25), with EBITDA Margin of 25.1%;
• EBIT: Euro 9.6 million, +13.4% (Euro 8.5 million in H1 24-25);
• Net Profit: Euro 7.3 million, +9.9% (Euro 6.6 million in H1 24-25);
• Net cash position of Euro 70.8 million (cash position of Euro 62.4 million at June 30, 2025)
• Shareholders' Equity: Euro 86.7 million (Euro 81.6 million at June 30, 2025);
• Backlog amounting to Euro 1.9 billion.

Castegnato (Brescia), March 30, 2026 - The Board of Directors of A.B.P. Nocivelli S.p.A., an EsCo Company specialised in building technological systems and facility management services, and a nationwide Public-Private Partnership clinic and hospital construction leader, listed on the Euronext Growth Milan's segment (ISIN Code IT0005439861, Ticker ABP:IM), in a meeting today chaired by Bruno Nocivelli, approved the half-year report at December 31, 2025, which presents solid growth for all KPI's, together with a further increase in operating profitability.

existing portfolio. We therefore look forward to continuing on this development trajectory and to the start up of the major initiatives expected over the coming years.

The Value of Production amounted to Euro 45.6 million, up 8.2% on Euro 42.1 million in H1 24-25. This growth is even more significant when excluding the revenues from the sale of petroleum products in 2024 (whose business unit has been closed), which therefore resulted in an adjusted 2024 Value of Production of Euro 40.6 million, with like-for-like growth of 12.4%. The improvement was driven both by sales revenues and from the contribution of works-in-progress and under completion.

25. The growth is mainly attributable to the strong increase in the plant construction component (Euro 16.8 million vs Euro 8.8 million YoY), which reflects the completion of major projects. In particular, this concerns the operational advancement of orders in portfolio and the progressive completion of works-in-progress, within an environment which continues to benefit also from the final phase of execution of a number of National Recovery and Resilience Plan (PNRR) works.

+6.1%).

growth, while maintaining at the same time a particularly solid financial structure and strong cash generation.

The Backlog at December 31, 2025 amounts to Euro 1.9 billion. The order backlog comprises the orders already awarded and contracted, usually of multi-year duration, such as Public Concessions and long-term contracts. This composition enables the company to rely on recurring cash flows, supported by solid profitability and ongoing cash generation.

On July 24, 2025, Nocivelli, in a temporary consortium (RTI) with Consorzio Stabile SIS S.c.p.A., won the tender for the construction and management of the "City of Health and Science" in Novara. The PPP (Public-Private Partnership) contract will have a duration of 30 years, including 5 years of works for the construction of buildings and plant and the subsequent 25 years of management of the plant services supporting the project. The total expected revenue value for the entire duration of the concession (30 years) is Euro 1.2 billion, including financial charges, works and services under the responsibility of both Consorzio Stabile S.c.p.A. and Nocivelli ABP. Nocivelli ABP's share is approx. Euro 400 million, consisting of approx. Euro 200 million for the construction of the works, in the first five years, and a further approx. Euro 200 million in the next 25 years for plant management services.

The Company announced on March 24, 2026 that it has appointed MIT SIM S.p.A. as Specialist Operator, which will take over from Banca Akros effective May 4, 2026 inclusive. The Corporate Broking and Research activities will remain with Banca Akros.

The company expects to maintain over the coming years strong levels of profitability. Industrial, commercial and service operations are continuing on schedule, while the already contracted services continue to be delivered on schedule and profitably. The Company also continues to participate in major bidding procedures, with a focus on conventions and tenders related to the upgrading of healthcare and hospital facilities, particularly for modernisation and regulatory upgrades, including those in the areas of earthquake and fire prevention.

Regarding the contracts financed with National Recovery and Resilience Plan (NRRP) funds, the Company is regularly continuing the executive activities, with delivery expected within the next two fiscal years. Works on the technological facilities under the contract for the rail link between the T2 Malpensa line and the RFI Simplon line have been completed.

The interventions for the installation of technological systems in two Assisted Healthcare Facilities (RSA) have also been completed, as part of the contracts related to the Superbonus 110%.

With reference to Terna S.p.A., the Company, which has qualified as a supplier with a ceiling of Euro 25 million, is completing the work related to the already awarded contracts, for a total value of approximately Euro 10 million. The Company has also participated and continues to participate in additional tender procedures called by Terna, which are expected to be awarded by June 30, 2026. Once obtaining supplier qualification for Enel S.p.A., RFI

It is reported that the preliminary activities to support the Conference of Services for the Public Private Partnership contract for the construction of the Health, Research and Innovation Park of the City of Turin have been started. In February 2026, the Extraordinary Commissioner was appointed in reference to the bidding process for the construction and management concession of the City of Health and Science in Novara, which will be followed by the start of preparatory activities for the Services Conference, expected to occur in the first half of 2026. Both projects are key steps in the company's development, whose major operating and financial benefits are expected to emerge from FY 2026-2027.

The company is constantly monitoring the development of the geopolitical tensions in the Middle East and the possible impacts on the energy markets. Although there are no direct trade exposures to the area, the recent increase in gas prices is a concerning factor, as it is potentially relevant to supply costs. The economic impact for the Company is mitigated by the presence of contractual mechanisms that allow these changes to be passed on to customers through specific fee adjustment clauses. This structure enables the containment of the risk of margin compression and supports the continuity of services provided to the client.

On March 31, 2026 at 11AM CET, Nocivelli ABP's Management will hold a conference call to present the half-year results at December 31, 2025 to the financial community.

You may participate in the conference call by connecting to the following link: https://us06web.zoom.us/meetings/82742886974/invitations?signature=Lbi3yJWO9SRVAq Yr1Ap9vjaIyQmOxdKbsYmk5WHSihk

The support documentation shall be published in the "Investor Relations" section on the

company website (https://www.abpnocivelli.it)) before the conference call.

The Executive Responsible for Financial Reporting, Mr. Bruno Nocivelli, declares in accordance with Article 154-bis, paragraph 2, of the Consolidated Finance Act, that the accounting information contained in the present press release corresponds to the underlying accounting documents, records and accounting entries.

The key financial statements comprising the Income Statement, Statement of Financial Position and the Net Financial Position for the HY to December 31, 2025 are presented on the following pages.

***

This Press Release is available on the company website at https://www.abpnocivelli.com, in the

"Investor Relations/Press Releases" section and at https://www.1info.it.

The half-year report at December 31, 2025, together with all the related reports, is available on the company website at https://www.abpnocivelli.com in the "Investor Relations/Financial Statements and Reports" section and on the https://www.borsaitaliana.it website in the Shares/Documents section.

***

Nocivelli ABP was founded in Castegnato (Brescia) in 1963 and initially traded in petroleum products and lubricants. In 1988 it diversified into the construction of technological, mechanical and electrical systems, in addition to civil and industrial construction and Facility Management. It is today a national leader in Public Private Partnership (PPP) operations for the construction of healthcare and hospital facilities. The Company is headquartered in Castegnato (BS) and has operations in Brescia, Novara and Ponderano (Biella). Bruno Nocivelli is the Chairperson of the Board of Directors, while Nicola Turra serves as Chief Executive Officer. The Company's results for the financial year ended June 30, 2025, showed a Value of Production of Euro 85.2 million, with EBITDA of Euro 16.8 million and a Net Profit of Euro

11.5 million.

Contacts

ABP Nocivelli S.p.A. Investor Relations Manager

Strada Padana Superiore Alessandra Perego

No. 67 25045 Castegnato (BS) Tel: + 39 030 2142011

https://www.abpnocivelli.com Email: investor.relations@abpnocivelli.com

Email: nocivelli@mytwincommunication.com Federico Bagatella | Tel: +39 3318007258 Giorgia Fenaroli | Tel: + 39 3342208486

Email: ecm@mediolanum.it